IL-38: A new factor in rheumatoid arthritis.
IL-38: A new factor in rheumatoid arthritis.
复制标题
DOI:
10.1016/j.bbrep.2015.10.015
复制
发表时间:
2015-12
影响因子:
2.7
通讯作者:
Hoshino T
中科院分区:
文献类型:
--
作者:
Takenaka SI;Kaieda S;Kawayama T;Matsuoka M;Kaku Y;Kinoshita T;Sakazaki Y;Okamoto M;Tominaga M;Kanesaki K;Chiba A;Miyake S;Ida H;Hoshino T
The newly characterized cytokine IL-38 (IL-1F10) belongs to the IL-1 family of cytokines. Previous work has demonstrated that IL-38 inhibited Candida albicans-induced IL-17 production from peripheral blood mononuclear cells. However, it is still unclear whether IL-38 is an inflammatory or an anti-inflammatory cytokine. We generated anti-human IL-38 monoclonal antibodies in order to perform immunohistochemical staining and an enzyme-linked immunosorbent assay. While human recombinant IL-38 protein was not cleaved by recombinant caspase-1, chymase, or PR3 in vitro, overexpression of IL-38 cDNA produced a soluble form of IL-38 protein. Furthermore, immunohistochemical analysis showed that synovial tissues obtained from RA patients strongly expressed IL-38 protein. To investigate the biological role of IL-38, C57BL/6 IL-38 gene-deficient (−/−) mice were used in an autoantibody-induced rheumatoid arthritis (RA) mouse model. As compared with control mice, IL-38 (−/−) mice showed greater disease severity, accompanied by higher IL-1β and IL-6 gene expression in the joints. Therefore, IL-38 acts as an inhibitor of the pathogenesis of autoantibody-induced arthritis in mice and may have a role in the development or progression of RA in humans. The soluble form of IL-38 is detected in the sera obtained from of RA patients. IL-38 protein was highly expressed in the synovial lining of RA synovium. IL-38 expression was up-regulated during arthritis in mice at the mRNA level. IL-38 may attenuate joint inflammation by inhibiting the IL-1 induced inflammation.